| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a42154c466cac7a9d1f9b28ada35d42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0b9f2fead64c18103b75399f99dfbc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6151f82ca42585753b2db0a37c0ed83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ee30edc92b04d2118a9305e4bc5ea3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ded0f2b9bb89628b514c5b7ff5c4fb0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2007-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30748150b84a093f89e434f682a71d7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30ddfb54a3b07c41cafcc52084bb434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f757257772f91e8fd5ec86f3bbf9e979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca589ff0d0e34eca156b37872f439227 |
| publicationDate |
2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009079837-A1 |
| titleOfInvention |
A pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein |
| abstract |
A pharmaceutical formulation contains recombinant human serum albumin-interferon alpha fusion protein (rHSA-IFNα). The pharmaceutical formulation comprises 0.1-5 mg/ml rHSA-IFNα and a stabilizing adjuvant of glycine or methionine dissolved in buffer solution having a pH of 5.0-8.0. The pharmaceutical formulation has storage stability. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106421755-A |
| priorityDate |
2007-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |